Oruka Therapeutics, Inc.
ORKA
$10.20
-$0.25-2.39%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.57% | 2,617.25% | -45.50% | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | -41.13% | 45.54% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | -8.74% | 2,354.96% | -39.37% | ||
|
|
|||||
| Total Current Assets | -8.74% | 2,354.96% | -39.37% | ||
| Net Property, Plant & Equipment | -5.46% | 9.91% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 0.00% | -98.18% | 383.20% | ||
| Total Assets | -4.36% | 1,952.19% | -28.53% | ||
|
|
|||||
| Total Accounts Payable | 61.40% | -16.83% | 64,375.00% | ||
| Total Accrued Expenses | 16.13% | -50.48% | 131.49% | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 45.89% | 139.34% | -- | ||
| Total Finance Division Other Current Liabilities | -- | 1,686.28% | 246.77% | ||
| Total Other Current Liabilities | -- | 1,686.28% | 246.77% | ||
| Total Current Liabilities | -27.70% | -6.82% | 170.20% | ||
|
|
|||||
| Total Current Liabilities | -27.70% | -6.82% | 170.20% | ||
| Long-Term Debt | -- | -- | 0.01% | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -10.33% | -8.97% | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | 349.07% | ||
| Total Liabilities | -26.92% | -59.16% | 42.86% | ||
|
|
|||||
| Common Stock & APIC | 16.53% | 117,121.24% | 1,783.33% | ||
| Retained Earnings | -44.49% | -97.62% | -314.30% | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 11.74% | 1,271.24% | -310.55% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -94.74% | 1,802.83% | 0.00% | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -94.74% | 1,802.83% | 0.00% | ||
|
|
|||||
| Total Common Equity | 11.74% | 1,271.24% | -310.55% | ||
| Total Preferred Equity | -94.74% | 1,802.83% | 0.00% | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -3.29% | 1,617.12% | -531.06% | ||
|
|
|||||